Key points are not available for this paper at this time.
Design
Review
Historical synthesis of beta-blocker evolution informs acute use; leaves open prospective validation of ultra-short-acting agents.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Kamiyama et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: